Global Intravascular Ultrasound (IVUS) Market to Reach $849.6 Million by 2026

Abstract: Global Intravascular Ultrasound (IVUS) Market to Reach $849. 6 Million by 2026 . Demand for medical ultrasound equipment worldwide is being spurred by expanding clinical utility and availability of high quality solutions.

New York, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Intravascular Ultrasound (IVUS) Industry" - https://www.reportlinker.com/p01375384/?utm_source=GNW
An estimated 180-million ultrasound procedures are conducted each year around the world. The increasing demand for medical ultrasound equipment is also attributable to pressure on hospitals and office-based physicians to cut healthcare costs. The trend towards miniaturization along with system portability and affordability has further unfolded the potential use of ultrasound in various settings. Ultrasound has emerged as an important tool for treatment planning for trauma patients in emergency situations, and also offers image guidance while performing procedures such as biopsies and regional anaesthesia. As ultrasound systems for point of care become affordable, lighter, more accessible, and easier to use, their adoption is expected to increase significantly in future. Effective pricing strategies and high technological content are definitely the winning cards. Intravascular Ultrasound (IVUS) is a diagnostic procedure performed to get real-time view of the inside of a coronary artery. IVUS is a catheter-based medical imaging methodology that allows medical professionals to know the level of stenosis, which is degree of thickening or narrowing of an artery. The method provides a visual image of the lumen or the inside of the artery, and the atheroma, which is the membrane or the cholesterol-loaded white blood cells, which remain hidden inside the artery wall. Physicians generally image the lining of an artery using IVUS in preparation for, or during an arthrectomy or angioplasty. IVUS is also used to view the results of the procedure, and in the placement of stents.

Amid the COVID-19 crisis, the global market for Intravascular Ultrasound (IVUS) estimated at US$569.4 Million in the year 2020, is projected to reach a revised size of US$849.6 Million by 2026, growing at a CAGR of 6.9% over the analysis period 2020-2027.IVUS Catheters, one of the segments analyzed in the report, is projected to grow at a 7.6% CAGR to reach US$514 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the IVUS Consoles segment is readjusted to a revised 6% CAGR for the next 7-year period. This segment currently accounts for a 33.8% share of the global Intravascular Ultrasound (IVUS) market.

The U.S. Market is Estimated at $218.2 Million in 2021, While China is Forecast to Reach $135.7 Million by 2026

The Intravascular Ultrasound (IVUS) market in the U.S. is estimated at US$218.2 Million in the year 2021. The country currently accounts for a 36.55% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$135.7 Million in the year 2026 trailing a CAGR of 9.3% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.8% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR while Rest of European market (as defined in the study) will reach US$148.5 Million by the close of the analysis period. The market is expected to post a steady growth in the coming years on account of increasing cases of coronary artery disease. IVUS holds enormous potential in terms of its ability to address unmet needs in the early detection and intervention of coronary artery diseases. IVUS technology is used for visualizing and assessing the plaque build-up and coronary lesions. In addition to assessment of coronary lesions, IVUS is being increasingly used in placement of stent in percutaneous coronary intervention. Capabilities to provide images of surrounding tissue as well as to provide high-resolution images have made the technology an attractive tool in assessing the stent size need for PCI procedures. Superior assessment of the blocked vessels also enables IVUS to effectively select and place stents within the vessels for restoration of normal flow of blood in the blocked vessel. IVUS helps in assessing appropriate placement of the stent, and to also to check for complete expansion of the stent. Overall adoption of intravascular ultrasound systems is facilitated by increasing number of stent procedures, coupled with rising demand for minimally-invasive procedures. The market growth is likely to be propelled by growing prevalence of cardiovascular diseases, rising obese and geriatric population, and sedentary lifestyles. Each year, approximately 17.7 million people die globally due to cardiovascular complications.

By Application, Coronary Intervention Segment to Reach $443.1 Million by 2026

Global market for Coronary Intervention (Application) segment is estimated at US$289.2 Million in 2020, and is projected to reach US$443.1 Million by 2026 reflecting a compounded annual growth rate of 7.4% over the analysis period. The United States constitutes the largest regional market for Coronary Intervention segment, accounting for 34.6% of the global sales in 2020. China is poised to register the fastest compounded annual growth rate of 9.7% over the analysis period, to reach US$87.5 Million by the end of the analysis period.
Select Competitors (Total 15 Featured)

• Boston Scientific Corporation

• Infraredx™, Inc.

• Koninklijke Philips N.V. (Royal Philips)

• Terumo Corp.

Read the full report: https://www.reportlinker.com/p01375384/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Medical Ultrasound: An Overview
Comparison of Ultrasound against Other Imaging Modalities
Application Areas
Coronary Artery Disease (CAD) - A Perspective
Causes and Symptoms
Percutaneous Coronary Intervention (PCI) - A Common Treatment
for CAD
Intravascular Ultrasound (IVUS) - High Potential in
Interventional Cardiology
Indications
Techniques of Intravascular Ultrasound
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual
% Change) for 2020 through 2022
Impact of COVID-19 on Intravascular Ultrasound Market
Point-of-care IntraVascular Ultrasound Gains Prominence
GLOBAL MARKET OVERVIEW
Global Intravascular Ultrasound Market to Witness Fastest Growth
Growth Drivers
IVUS Catheters Remain the Key Revenue Spinners
US and Europe Dominate, Asia-Pacific to Witness Fastest Growth
Hospitals Account for the Largest Share
Competition
Select Approved IVUS Catheters in the Market
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Rise in Incidence of Cardiovascular Diseases Drives Demand for
Intravascular Ultrasound
EXHIBIT 2: Global Cardiovascular Ultrasound Procedure Share: 2020E
IVUS Addresses Growing Need for Minimally Invasive Procedures
Global Menace of Coronary Artery Disease (CAD) - A Major Growth
Driver
EXHIBIT 3: Global Annual Medical Cost of CVD in the United
States: 2015-2030
EXHIBIT 4: Fatalities by Heart Conditions - Estimated
Percentage Breakdown for Cardiovascular Disease, Ischemic
Heart Disease, Stroke, and Others
Stents Transform CAD Treatment, IVUS Expands Efficacy
Superior Capabilities over Angiography Propels IVUS Adoption
IVUS Inches Forward to Become Standard Choice for Vascular &
Arterial Interventions
Angiography vs. IVUS to Measure Vascular Characteristics
IVUS vs. Venography for Venous Interventions
Select List of Studies Comparing Venography to IVUS
IVUS for Arterial Interventions
Advancements in Ultrasound Technology to Benefit Market Growth
Study Links IVUS-Guided PCI with Better Long-Term Patient
Outcomes & Low Cardiac Death Risk
Use of IVUS Increases in the Diagnosis of Complex CTO Lesions
Contrast Agents Expand Ultrasound Applications
Rapid Adoption of Contrast-Enhanced Ultrasound (CEUS) Unfurls
New Growth Opportunities
Advanced Ultrasound Transducer Designs Simplify IVUS Imaging
Applications
Rapidly Growing Geriatric Population and the Rise in Associated
Diseases Catalyze Growth
EXHIBIT 5: Global Population Statistics for the 65+ Age Group
in Million by Geographic Region for the Years 2019, 2025, 2035
and 2050
EXHIBIT 6: Elderly Population (65+ Years) as a % of Total
Population by Developed, Less Developed and Least Developed
Regions: 2019 & 2030
Rising Middle Class Population Aids Growth
EXHIBIT 7: Global Middle Class Population (in Millions) by
Geographic Region: 2010, 2020E & 2030P
Rising Healthcare Expenditure: Opportunities in Store
EXHIBIT 8: World Healthcare Expenditure (In US$ Billion) for
the Years 2017-2023
EXHIBIT 9: Healthcare Costs as a % of GDP by Country for the
Years 2020 & 2023
Risk of CAD in Obesity Offers Prospects for IVUS
EXHIBIT 10: Obesity Prevalence Rate (%) in Select Countries for
the Years 2019 and 2030P
The Hypertension-Cholesterol Link to Drive Demand
EXHIBIT 11: Hypertension Prevalence (%) Worldwide by Region in
Male and Females Aged 25+ Years
Diabetics at Higher Risk of Heart Diseases
EXHIBIT 12: Diabetes Prevalence Worldwide by Region: Number of
Adults (20-79 Years) with Diabetes in 2015 and 2040
Use of Blockchain in Diagnostic Imaging

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Intravascular
Ultrasound (IVUS) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Intravascular Ultrasound
(IVUS) by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Intravascular Ultrasound
(IVUS) by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2020 & 2027

Table 4: World Current & Future Analysis for IVUS Catheters by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for IVUS Catheters by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for IVUS Catheters by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for IVUS Consoles by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for IVUS Consoles by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for IVUS Consoles by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Other Products by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Other Products by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Other Products by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Coronary
Intervention by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Coronary Intervention by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Coronary Intervention
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Coronary
Diagnosis by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Coronary Diagnosis by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Coronary Diagnosis by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Coronary Research
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Coronary Research by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Coronary Research by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for
Non-Coronary/Peripheral by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Non-Coronary/Peripheral by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Non-Coronary/Peripheral
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 27: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Diagnostic
Imaging Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Diagnostic Imaging Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Diagnostic Imaging
Centers by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 31: World Current & Future Analysis for Specialty Clinics
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 32: World Historic Review for Specialty Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 33: World 15-Year Perspective for Specialty Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 34: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 35: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 36: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 37: USA Current & Future Analysis for Intravascular
Ultrasound (IVUS) by Product - IVUS Catheters, IVUS Consoles
and Other Products - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 38: USA Historic Review for Intravascular Ultrasound
(IVUS) by Product - IVUS Catheters, IVUS Consoles and Other
Products Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 39: USA 15-Year Perspective for Intravascular Ultrasound
(IVUS) by Product - Percentage Breakdown of Value Sales for
IVUS Catheters, IVUS Consoles and Other Products for the Years
2012, 2020 & 2027

Table 40: USA Current & Future Analysis for Intravascular
Ultrasound (IVUS) by Application - Coronary Intervention,
Coronary Diagnosis, Coronary Research and
Non-Coronary/Peripheral - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 41: USA Historic Review for Intravascular Ultrasound
(IVUS) by Application - Coronary Intervention, Coronary
Diagnosis, Coronary Research and Non-Coronary/Peripheral
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 42: USA 15-Year Perspective for Intravascular Ultrasound
(IVUS) by Application - Percentage Breakdown of Value Sales for
Coronary Intervention, Coronary Diagnosis, Coronary Research
and Non-Coronary/Peripheral for the Years 2012, 2020 & 2027

Table 43: USA Current & Future Analysis for Intravascular
Ultrasound (IVUS) by End-Use - Hospitals, Diagnostic Imaging
Centers, Specialty Clinics and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 44: USA Historic Review for Intravascular Ultrasound
(IVUS) by End-Use - Hospitals, Diagnostic Imaging Centers,
Specialty Clinics and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 45: USA 15-Year Perspective for Intravascular Ultrasound
(IVUS) by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Diagnostic Imaging Centers, Specialty Clinics and
Other End-Uses for the Years 2012, 2020 & 2027

CANADA
Table 46: Canada Current & Future Analysis for Intravascular
Ultrasound (IVUS) by Product - IVUS Catheters, IVUS Consoles
and Other Products - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 47: Canada Historic Review for Intravascular Ultrasound
(IVUS) by Product - IVUS Catheters, IVUS Consoles and Other
Products Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 48: Canada 15-Year Perspective for Intravascular
Ultrasound (IVUS) by Product - Percentage Breakdown of Value
Sales for IVUS Catheters, IVUS Consoles and Other Products for
the Years 2012, 2020 & 2027

Table 49: Canada Current & Future Analysis for Intravascular
Ultrasound (IVUS) by Application - Coronary Intervention,
Coronary Diagnosis, Coronary Research and
Non-Coronary/Peripheral - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 50: Canada Historic Review for Intravascular Ultrasound
(IVUS) by Application - Coronary Intervention, Coronary
Diagnosis, Coronary Research and Non-Coronary/Peripheral
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 51: Canada 15-Year Perspective for Intravascular
Ultrasound (IVUS) by Application - Percentage Breakdown of
Value Sales for Coronary Intervention, Coronary Diagnosis,
Coronary Research and Non-Coronary/Peripheral for the Years
2012, 2020 & 2027

Table 52: Canada Current & Future Analysis for Intravascular
Ultrasound (IVUS) by End-Use - Hospitals, Diagnostic Imaging
Centers, Specialty Clinics and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 53: Canada Historic Review for Intravascular Ultrasound
(IVUS) by End-Use - Hospitals, Diagnostic Imaging Centers,
Specialty Clinics and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 54: Canada 15-Year Perspective for Intravascular
Ultrasound (IVUS) by End-Use - Percentage Breakdown of Value
Sales for Hospitals, Diagnostic Imaging Centers, Specialty
Clinics and Other End-Uses for the Years 2012, 2020 & 2027

JAPAN
Table 55: Japan Current & Future Analysis for Intravascular
Ultrasound (IVUS) by Product - IVUS Catheters, IVUS Consoles
and Other Products - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 56: Japan Historic Review for Intravascular Ultrasound
(IVUS) by Product - IVUS Catheters, IVUS Consoles and Other
Products Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 57: Japan 15-Year Perspective for Intravascular
Ultrasound (IVUS) by Product - Percentage Breakdown of Value
Sales for IVUS Catheters, IVUS Consoles and Other Products for
the Years 2012, 2020 & 2027

Table 58: Japan Current & Future Analysis for Intravascular
Ultrasound (IVUS) by Application - Coronary Intervention,
Coronary Diagnosis, Coronary Research and
Non-Coronary/Peripheral - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 59: Japan Historic Review for Intravascular Ultrasound
(IVUS) by Application - Coronary Intervention, Coronary
Diagnosis, Coronary Research and Non-Coronary/Peripheral
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 60: Japan 15-Year Perspective for Intravascular
Ultrasound (IVUS) by Application - Percentage Breakdown of
Value Sales for Coronary Intervention, Coronary Diagnosis,
Coronary Research and Non-Coronary/Peripheral for the Years
2012, 2020 & 2027

Table 61: Japan Current & Future Analysis for Intravascular
Ultrasound (IVUS) by End-Use - Hospitals, Diagnostic Imaging
Centers, Specialty Clinics and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 62: Japan Historic Review for Intravascular Ultrasound
(IVUS) by End-Use - Hospitals, Diagnostic Imaging Centers,
Specialty Clinics and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 63: Japan 15-Year Perspective for Intravascular
Ultrasound (IVUS) by End-Use - Percentage Breakdown of Value
Sales for Hospitals, Diagnostic Imaging Centers, Specialty
Clinics and Other End-Uses for the Years 2012, 2020 & 2027

CHINA
Table 64: China Current & Future Analysis for Intravascular
Ultrasound (IVUS) by Product - IVUS Catheters, IVUS Consoles
and Other Products - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 65: China Historic Review for Intravascular Ultrasound
(IVUS) by Product - IVUS Catheters, IVUS Consoles and Other
Products Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 66: China 15-Year Perspective for Intravascular
Ultrasound (IVUS) by Product - Percentage Breakdown of Value
Sales for IVUS Catheters, IVUS Consoles and Other Products for
the Years 2012, 2020 & 2027

Table 67: China Current & Future Analysis for Intravascular
Ultrasound (IVUS) by Application - Coronary Intervention,
Coronary Diagnosis, Coronary Research and
Non-Coronary/Peripheral - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 68: China Historic Review for Intravascular Ultrasound
(IVUS) by Application - Coronary Intervention, Coronary
Diagnosis, Coronary Research and Non-Coronary/Peripheral
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 69: China 15-Year Perspective for Intravascular
Ultrasound (IVUS) by Application - Percentage Breakdown of
Value Sales for Coronary Intervention, Coronary Diagnosis,
Coronary Research and Non-Coronary/Peripheral for the Years
2012, 2020 & 2027

Table 70: China Current & Future Analysis for Intravascular
Ultrasound (IVUS) by End-Use - Hospitals, Diagnostic Imaging
Centers, Specialty Clinics and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 71: China Historic Review for Intravascular Ultrasound
(IVUS) by End-Use - Hospitals, Diagnostic Imaging Centers,
Specialty Clinics and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 72: China 15-Year Perspective for Intravascular
Ultrasound (IVUS) by End-Use - Percentage Breakdown of Value
Sales for Hospitals, Diagnostic Imaging Centers, Specialty
Clinics and Other End-Uses for the Years 2012, 2020 & 2027

EUROPE
Table 73: Europe Current & Future Analysis for Intravascular
Ultrasound (IVUS) by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 74: Europe Historic Review for Intravascular Ultrasound
(IVUS) by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 75: Europe 15-Year Perspective for Intravascular
Ultrasound (IVUS) by Geographic Region - Percentage Breakdown
of Value Sales for France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets for Years 2012, 2020 & 2027

Table 76: Europe Current & Future Analysis for Intravascular
Ultrasound (IVUS) by Product - IVUS Catheters, IVUS Consoles
and Other Products - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 77: Europe Historic Review for Intravascular Ultrasound
(IVUS) by Product - IVUS Catheters, IVUS Consoles and Other
Products Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 78: Europe 15-Year Perspective for Intravascular
Ultrasound (IVUS) by Product - Percentage Breakdown of Value
Sales for IVUS Catheters, IVUS Consoles and Other Products for
the Years 2012, 2020 & 2027

Table 79: Europe Current & Future Analysis for Intravascular
Ultrasound (IVUS) by Application - Coronary Intervention,
Coronary Diagnosis, Coronary Research and
Non-Coronary/Peripheral - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 80: Europe Historic Review for Intravascular Ultrasound
(IVUS) by Application - Coronary Intervention, Coronary
Diagnosis, Coronary Research and Non-Coronary/Peripheral
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 81: Europe 15-Year Perspective for Intravascular
Ultrasound (IVUS) by Application - Percentage Breakdown of
Value Sales for Coronary Intervention, Coronary Diagnosis,
Coronary Research and Non-Coronary/Peripheral for the Years
2012, 2020 & 2027

Table 82: Europe Current & Future Analysis for Intravascular
Ultrasound (IVUS) by End-Use - Hospitals, Diagnostic Imaging
Centers, Specialty Clinics and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 83: Europe Historic Review for Intravascular Ultrasound
(IVUS) by End-Use - Hospitals, Diagnostic Imaging Centers,
Specialty Clinics and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 84: Europe 15-Year Perspective for Intravascular
Ultrasound (IVUS) by End-Use - Percentage Breakdown of Value
Sales for Hospitals, Diagnostic Imaging Centers, Specialty
Clinics and Other End-Uses for the Years 2012, 2020 & 2027

FRANCE
Table 85: France Current & Future Analysis for Intravascular
Ultrasound (IVUS) by Product - IVUS Catheters, IVUS Consoles
and Other Products - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 86: France Historic Review for Intravascular Ultrasound
(IVUS) by Product - IVUS Catheters, IVUS Consoles and Other
Products Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 87: France 15-Year Perspective for Intravascular
Ultrasound (IVUS) by Product - Percentage Breakdown of Value
Sales for IVUS Catheters, IVUS Consoles and Other Products for
the Years 2012, 2020 & 2027

Table 88: France Current & Future Analysis for Intravascular
Ultrasound (IVUS) by Application - Coronary Intervention,
Coronary Diagnosis, Coronary Research and
Non-Coronary/Peripheral - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 89: France Historic Review for Intravascular Ultrasound
(IVUS) by Application - Coronary Intervention, Coronary
Diagnosis, Coronary Research and Non-Coronary/Peripheral
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 90: France 15-Year Perspective for Intravascular
Ultrasound (IVUS) by Application - Percentage Breakdown of
Value Sales for Coronary Intervention, Coronary Diagnosis,
Coronary Research and Non-Coronary/Peripheral for the Years
2012, 2020 & 2027

Table 91: France Current & Future Analysis for Intravascular
Ultrasound (IVUS) by End-Use - Hospitals, Diagnostic Imaging
Centers, Specialty Clinics and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 92: France Historic Review for Intravascular Ultrasound
(IVUS) by End-Use - Hospitals, Diagnostic Imaging Centers,
Specialty Clinics and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 93: France 15-Year Perspective for Intravascular
Ultrasound (IVUS) by End-Use - Percentage Breakdown of Value
Sales for Hospitals, Diagnostic Imaging Centers, Specialty
Clinics and Other End-Uses for the Years 2012, 2020 & 2027

GERMANY
Table 94: Germany Current & Future Analysis for Intravascular
Ultrasound (IVUS) by Product - IVUS Catheters, IVUS Consoles
and Other Products - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 95: Germany Historic Review for Intravascular Ultrasound
(IVUS) by Product - IVUS Catheters, IVUS Consoles and Other
Products Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 96: Germany 15-Year Perspective for Intravascular
Ultrasound (IVUS) by Product - Percentage Breakdown of Value
Sales for IVUS Catheters, IVUS Consoles and Other Products for
the Years 2012, 2020 & 2027

Table 97: Germany Current & Future Analysis for Intravascular
Ultrasound (IVUS) by Application - Coronary Intervention,
Coronary Diagnosis, Coronary Research and
Non-Coronary/Peripheral - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 98: Germany Historic Review for Intravascular Ultrasound
(IVUS) by Application - Coronary Intervention, Coronary
Diagnosis, Coronary Research and Non-Coronary/Peripheral
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR


Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p01375384/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001